Freeline Therapeutics



Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.

Michael Parini
President & COO
Markus Hörer
Founder, CTO & Managing Director GmbH
Julie Krop
Chief Medical Officer
Jan Thirkettle
Chief Development Officer
Romuald Corbau
Chief Scientific Officer
Mark Baldry
Chief Commercial Officer
Stephen Diamond
SVP & General Counsel
Duncan Whitaker
VP of Intellectual Property
Lyndsay Telakis
VP of HR
David Arrington
VP of Investor Relations & Corporate Communications
Benjamin Warriner
VP of Finance

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.